Abstract: The present invention relates to a compound having the following formula (I): as well as the corresponding prodrugs, pharmaceutical compositions comprising said compounds, in particular for treating cancer.
Type:
Grant
Filed:
May 6, 2020
Date of Patent:
November 4, 2025
Assignees:
SEEKYO, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE